Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 9.3B | 9.2B | 9.1B | 8.7B |
Cost of revenue | 7.3B | 7.2B | 7.3B | 7.0B |
Gross profit | 2.0B | 1.9B | 1.9B | 1.7B |
Operating expense | ||||
Research & development | 192M | 187M | 188M | 182M |
Selling general and admin | 80M | 90M | 94M | 121M |
Other operating expenses | — | — | — | — |
Operating income | 1.7B | 1.6B | 1.6B | 1.4B |
Non operating interest income | ||||
Income | 45M | 52M | 38M | 38M |
Expense | 131M | 136M | 132M | 113M |
Other income expense | -216M | -54M | -80M | 35M |
Pretax income | 1.4B | 1.5B | 1.4B | 1.4B |
Tax provision | 269M | 289M | 276M | 259M |
Net income | 1.1B | 1.2B | 1.1B | 1.1B |
Basic EPS | 0.8 | 0.8 | 0.8 | 0.7 |
Diluted EPS | 0.8 | 0.8 | 0.8 | 0.7 |
Basic average shares | 1.4B | 1.4B | 1.4B | 1.4B |
Diluted average shares | 1.4B | 1.4B | 1.4B | 1.4B |
EBITDA | 1.8B | 2.4B | 2.3B | 2.1B |
Net income from continuing op. | 1.1B | 1.2B | 1.1B | 1.1B |
Minority interests | -23M | -32M | -33M | -30M |
Preferred stock dividends | — | — | — | — |